tiprankstipranks
Biolidics Ltd. (SG:8YY)
SGX:8YY
Singapore Market

Biolidics Ltd. (8YY) Financial Statements

Compare
1 Followers

Biolidics Ltd. Financial Overview

Biolidics Ltd.'s market cap is currently S$47.34M. The company's EPS TTM is S$-0.003; its P/E ratio is ―; Biolidics Ltd. is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is S$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 21Dec 20Dec 19Dec 18Dec 17
Income Statement
Total Revenue
Gross Profit$ 483.09K$ 3.44M$ 966.13K$ 880.13K$ 1.36M
Operating Income$ -3.31M$ -577.88K$ -2.34M$ -4.84M$ -1.72M
EBITDA$ -4.58M$ -3.56M$ -4.16M$ -5.28M$ -5.53M
Net Income$ -5.98M$ -4.65M$ -4.81M$ -6.25M$ -7.21M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 11.42M$ 18.76M$ 9.62M$ 14.19M$ 5.21M
Total Debt$ 4.25M$ 5.28M$ 536.63K$ 0.00$ 16.12M
Net Debt$ 289.48K$ -5.39M$ -5.49M$ -11.50M$ 13.66M
Total Liabilities$ 9.09M$ 10.48M$ 1.86M$ 1.63M$ 29.05M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -5.18M$ -2.88M$ -5.24M$ -4.89M$ -4.16M
Operating Cash Flow$ -4.62M$ -2.43M$ -4.56M$ -4.69M$ -3.72M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Biolidics Ltd. Earnings and Revenue History

Biolidics Ltd. Debt to Assets

Biolidics Ltd. Cash Flow

Biolidics Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis